Skip to main content
Premium Trial:

Request an Annual Quote

Jean-Francois Formela, Vijay Chandru

Premium

DeCode Genetics announced last week that Jean-Francois Formela has resigned from its board of directors.

Formela, a senior partner at Atlas Venture, has served on DeCode's board since the formation of the company in 1996. He resigned to devote his time to a new Atlas fund, the company said.

Atlas was among a group of venture firms that helped finance DeCode's start.


Vijay Chandru, the founder of Strand Genomics, was wounded when a gunman opened fire on a gathering of scientists at a conference at the Indian Institute of Science in Bangalore, India, last week.

According to a report in the Times of India, the 52-year-old Chandru, a professor at IIS, sustained bullet injuries in the shoulder and leg from the attack. The report stated that Chandru was declared "out of danger" following surgery.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.